October 03, 2006

Because I Am Lazy

And also because Liz Spikol does such a fine job digging up interesting things on her blog, I pass along this column from yesterday's Philly Inquirer bashing on America for what I'll call depression obsession syndrome. I don't disagree with the author, although I wish she'd gone after all these public health studies linking depression with everything under the sun and clouds—heart disease, diabetes, and every physical malady you can imagine. In other words, public health researchers are arguing that life is depressing and existence can be oppressive (all of it an argument for anyone with a physical ailemnt to take Prozac, I'm sure). Stop the fucking presses! And go read Jean-Paul Satre.

I wonder how public health and psych researchers feel about following the public health paradigm (every ailment is linked to something, study the link and eliminate the something by law or meds, no matter how benign) into such obvious minutiae and becoming tools, unwitting or not, of pharma companies and social control freaks. The media of course helps this along (especially, the AP and Reuters and your local television news) in ways that I will bang on another day. Keep in mind that researchers get paid big bucks for these studies and get to publish articles and advance their careers and make news. What America needs right now are a few more skeptical editors and news directors.

OK, I am not truly being lazy, but as some of you know, my attention is a bit divided these days by an outside project. Here's to hoping that my Burning Man neighbors decide to bust their respective nuts before 1 a.m.!

Posted by Philip Dawdy at October 3, 2006 12:01 AM
StumbleUpon Toolbar del.icio.us Digg it reddit
Comments

Hi, Philip. There's a lot of depression-stress studies that very convincingly show the link (though we have yet to definitely prove it) between depression and stress pathways. From the stress pathways it's easy to connect the biochemical dots to cellular damage to all kinds of things going wrong in the body. Some of these studies are done by people who stand to make a lot of money if a drug company comes up with a CRF antagonist or something similar, but this is America where our public researh funding for mental health is criminally low, which gives researchers no choice but to beg for drug company money.

I'm okay with this to a certain point, namely if a researcher finds something promising, we want a drug company to be figuring a way to make money off of it. And yes, some of the researchers have been corrupted and I can name names.

A different set of studies is far more pure, but they simply show linkage rather than causation. These are the epidemiogical studies that investigate large population cohorts and track them over years and decades. These studies show those who have had depression dropping off like flies to heart disease and what not compared to those with no depression. A link is different than a cause, but the body counts are pretty frightening any way you look at it.

One of these epidemiological studies found a 26 percent higher death rate in a depressed elderly population. I extrapolated these figures with CDC data (very unscientific of me) and came up with just under 600,000 deaths annually in the US that could conceivably be linked to depression, way more than the 30,000 annual death toll from suicide.

So here's the advocacy translation. Instead of dissing big pharma (which is like shooting fish in a barrel), let's do some in-your-face outrage at depression and bipolar's "true" body count. Keep pounding on the numbers, show what a real killer this illness is, make a strong case for the government putting as much research into mood disorders as they do into cancer and AIDS and heart disease, get our health system (such as it is) to put some real resources into prevention and treatment.

If the media is too dumb that's fine with me. It means they will run with our message. If we wind up with a lot more public funding for research as a result, then it means we're less dependent on drug companies for research, with far less corruption in the system. So, paradoxically, by not trashing big pharma this is the best antipharma campaign possible.

Okay, I've laid myself wide open here. Let the discussion begin.

Posted by: John McManamy at October 3, 2006 07:48 AM

pic1.jpg

Patient Blogs. Sites.
Doctor Blogs. Sites.
Activists. News.
Social Networking. Forums.
Science. Big Pharma. Ethics.
Current Affairs
Seattle Stuff
Smoking. Stuff.

Info
About Furious Seasons
Email
Other Articles
ZYPREXA Documents
Alt ZYPREXA Documents Source
Blakemore-Brown Transcript

 Subscribe in a reader

Recent Entries
Jim Carrey Criticizes Extended Anti-Depressant Use
FDA Orders Suicide Warning For Bipolar, Epilepsy Drugs
Another Seroquel Related Arrest
Minnesota Forced ECT Case Hits NPR Airwaves
Fundraiser Over
Boston Globe Reports Sexual Problems With SSRIs As High As 50 Percent
Winter Fundraiser, So Close It's Not Even Funny
Two Child Physicians Criticize ADHD Meds, The Bipolar Child, Pharma Influence
Michael Phelps: "I Didn't Want To Take Ritalin Anymore"
Winter Fundraiser, Oh So Close
Winter Fundraiser, Inching Closer
10-Year-Old Who Killed Father After Beginning Prozac Gets New Trial
Scientific American Interview: Is Depression Overdiagnosed?
Winter Fundraiser, Day 11
Paxil Documents Online
Recent Comments

John McManamy on Because I Am Lazy

Archives
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
March 2006
February 2006
January 2006
December 2005
November 2005
October 2005
September 2005
Resources
Mental Health America
National Alliance on Mental Illness
Depression and Bipolar Support Alliance
National Institute of Mental Health
McMan Web
Search


Powered by
Movable Type 3.2